摘要
目的探讨欣母沛预防宫缩乏力性产后出血的疗效、不良反应及护理。方法选取40例宫缩乏力性产后出血高危产妇,胎儿娩出后预防性予40 U缩宫素,将其分为观察组(欣母沛组)和对照组(米索前列醇组),观察组立即宫体注射欣母沛250μg,对照组宫体再次注射缩宫素20U并舌下含服米索前列醇400μg,期间给予全面护理并加强监测。比较2组用药后1 h、2 h及24 h出血量及不良反应发生率。结果观察组用药后1 h、1～2 h及2～24 h较对照组平均出血量减少,不良反应较轻,差异有统计学意义。结论欣母沛相比米索前列醇是更强有力的缩宫药,具有安全、高效、迅速、方便的特点,及早给予宫缩乏力性产后出血高危产妇欣母沛并结合积极有效的护理措施,能起到显著效果,可降低产妇的损伤。
Objective To investigate the Hmabate in managing in postpartum hemorrhage of Uterine atony,adverse reaction and nursing.Methods 40 cases of uterine atony at high risk of maternal postpartum hemorrhage,fetal childbirth after prophylactic to 40 u oxytocin,divided into the observation group（Hmabate group） and control group（Misoprostol group）,Hmabate group immediately from injection hin 250 ug.Control group from injection of oxytocin 20 u again and sublingual including rice line 400 μg.During a given comprehensive care and strengthen monitoring.Compare two groups after 1 h,2 h and 24 h blood loss and incidence of adverse reactions.Results Observation group than the control group after 1 h,1 to 2 h and 2~24 h average blood loss reduction,adverse reaction is lighter,the difference was statistically significant.Conclusions Hmabate repeatedly compared Misoprostol is stronger,and has the characteristics of safe,efficient,quick,convenient,give contractions fatigue sex early postpartum hemorrhage high-risk women Hmabate,combined with the positive and effective nursing measures,can play a significant effect,reduce maternal injuries.
出处
《实用临床医药杂志》
CAS
2013年第12期154-156,159,共4页
Journal of Clinical Medicine in Practice
